LCG
ISEE

Lisanti Capital Growth’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Lisanti Capital Growth’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-201,760
Closed -$4.32M – 163
2022
Q4 		$4.32M Buy
+201,760
New +$4.31M 0.59% 67
2016
Q1 		– Sell
-5,310
Closed -$417K – 115
2015
Q4 		$417K Buy
+5,310
New +$307K 0.44% 83
2014
Q3 		– Sell
-26,835
Closed -$1.14M – 113
2014
Q2 		$1.14M Buy
+26,835
New +$985K 0.51% 77

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lisanti Capital Growth's ISEE Position: Q1 2023 in Review

Lisanti Capital Growth sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 201,760 shares — an estimated $4.32M sold.

Lisanti Capital Growth first reported a position in ISEE in Q2 2014 and held it in 3 quarters. The position peaked at $4.32M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Lisanti Capital Growth reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Lisanti Capital Growth sold 201,760 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $4.32M.
  • Lisanti Capital Growth first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Lisanti Capital Growth's IVERIC bio, Inc. Common Stock position peaked at $4.32M in Q4 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Lisanti Capital Growth's 13F filing for Q1 2023, filed 8 May 2023.